At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 80 enrolled
Drug / intervention
Lidocaine paracervical block +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Paracervical Block During Office Hysteroscopy: A Randomized Double Blind Placebo-controlled Trial
In Brief
A Phase 2 clinical trial evaluating Lidocaine paracervical block and Normal Saline for Paracervical Block. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the effectiveness of paracervical block for pain relief in office hysteroscopy - particularly with the placement of the Essure device. Subjects will be randomized to receive either paracervical block or saline, and will have pain assessments performed throughout the procedure. Subjects and physicians will be blinded to group assignments.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParacervical Block
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2007
Primary CompletionMar 2008
Study CompletionSep 2008
First PostedDec 2008
TodayJul 2026
First PostedDec 18, 2008
Enrollment StartMar 1, 2007
Primary CompletionMar 1, 2008
Study CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 17.5 years ago
Interventions
Lidocaine paracervical blockdrug
5cc 1% lidocaine injection in each paracervical region
Normal Salinedrug
5cc Normal Saline injection in each paracervical region